Ubiquitin-specific peptidase 46 (Usp46) regulates mouse immobile behavior in the tail suspension test through the GABAergic system

• Published in: PloS one Vol. 7; no. 6; p. e39084
• Main Authors: Imai, Saki, Mamiya, Takayoshi, Tsukada, Akira, Sakai, Yasuyuki, Mouri, Akihiro, Nabeshima, Toshitaka, Ebihara, Shizufumi
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 14.06.2012; Public Library of Science (PLoS)
• Subjects: Agriculture; Animal cognition; Animals; Antidepressants; Artificial chromosomes; Base Sequence; Behavior; Benzodiazepines; Binding sites; Biology; Blotting, Northern; Caenorhabditis elegans; DNA Primers; Drugs; Endopeptidases - physiology; Enzymes; Flumazenil; Flumazenil - pharmacology; GABA; gamma-Aminobutyric Acid - metabolism; Gene deletion; Gene loci; Genes; Genomes; Hindlimb Suspension; Laws, regulations and rules; Lysine; Male; Medicine; Mental depression; Metabolism; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Nematodes; Nitrazepam; Nitrazepam - pharmacology; Peptidase; Pharmaceutical sciences; Pharmacology; Rodents; Sleep; Tail - physiology; Ubiquitin; Veterinary Science; γ-Aminobutyric acid A receptors; Japan
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0039084

The tail suspension test (TST) is widely recognized as a useful experimental paradigm for assessing antidepressant activity and depression-like behavior. We have previously identified ubiquitin-specific peptidase 46 (Usp46) as a quantitative trait gene responsible for decreasing immobility time in the TST in mice. This Usp46 mutation has a 3-bp deletion coding for lysine in the open reading frame, and we indicated that Usp46 is implicated in the regulation of the GABAergic system. However, it is not known precisely how the immobile behavior is regulated by the GABAergic system. Therefore, in the present study, we examined whether the immobility time is influenced by drugs affecting the action mediated by GABA(A) receptor using both 3-bp deleted (the Usp46 mutant) and null Usp46 (Usp46 KO) mice. Nitrazepam, an agonist at the benzodiazepine-binding site of the GABA(A) receptor, which potentiates the action of GABA, produced a dose-dependent increase in TST immobility time in the Usp46 mutant mice without affecting general behaviors. The Usp46 KO mice exhibited short immobility times comparable to the Usp46 mutant mice, which was also increased by nitrazepam administration. The effects of nitrazepam in the Usp46 mutant and KO mice were antagonized by flumazenil. These results indicate that the 3-bp deleted Usp46 mutation causes a loss-of-function phenotype, and that the GABA(A) receptor might participate in the regulation of TST immobility time.